3-O-beta-D-glucopyranosyl-28-O-beta-D-xylopyranosyl-(1→4)-alpha-L-rhamnopyranosyl-(1→2)-4-O-(3'-hydroxybutanoyloxy-3-hydroxybutanoyloxy)-beta-D-fucopyranosyl medicagenic acid - Compound Card

3-O-beta-D-glucopyranosyl-28-O-beta-D-xylopyranosyl-(1→4)-alpha-L-rhamnopyranosyl-(1→2)-4-O-(3'-hydroxybutanoyloxy-3-hydroxybutanoyloxy)-beta-D-fucopyranosyl medicagenic acid

Select a section from the left sidebar

3-O-beta-D-glucopyranosyl-28-O-beta-D-xylopyranosyl-(1→4)-alpha-L-rhamnopyranosyl-(1→2)-4-O-(3'-hydroxybutanoyloxy-3-hydroxybutanoyloxy)-beta-D-fucopyranosyl medicagenic acid

Structure
Zoomed Structure
  • Family: Plantae - Onagraceae
  • Kingdom: Plantae
  • Class: Terpene
Canonical Smiles OCC1OC(O)(O[C@H]2[C@@H](O)C[C@]3(C(C2(C)C)CC[C@@]2(C3CC=C3[C@@]2(C)CC[C@@]2(C3CC(C)(C)CC2)C(=O)OC2OC(C)C(C(C2OC2OC(C)C(C(C2O)O)OC2OCC(C(C2O)O)O)O)OC(=O)CC(OC(=O)CC(O)C)C)C)C)C(C(C1O)O)O
InChI InChI=1S/C61H98O26/c1-26(63)20-37(66)79-27(2)21-38(67)82-47-29(4)81-53(48(45(47)74)84-52-44(73)41(70)46(28(3)80-52)83-51-43(72)39(68)33(65)25-78-51)85-54(76)60-18-16-55(5,6)22-31(60)30-12-13-36-57(9)23-32(64)50(87-61(77)49(75)42(71)40(69)34(24-62)86-61)56(7,8)35(57)14-15-59(36,11)58(30,10)17-19-60/h12,26-29,31-36,39-53,62-65,68-75,77H,13-25H2,1-11H3/t26?,27?,28?,29?,31?,32-,33?,34?,35?,36?,39?,40?,41?,42?,43?,44?,45?,46?,47?,48?,49?,50-,51?,52?,53?,57-,58+,59+,60-,61?/m0/s1
InChIKey MZVLGURUWZNNTP-ZUKBTQIZSA-N
Formula C61H98O26
HBA 26
HBD 13
MW 1247.43
Rotatable Bonds 15
TPSA 406.5
LogP -0.41
Number Rings 9
Number Aromatic Rings 0
Heavy Atom Count 87
Formal Charge 0
Fraction CSP3 0.92
Exact Mass 1246.63
Number of Lipinski Rule Violations 3
# Species Family Kingdom NCBI Taxonomy ID
1 Ludwigia leptocarpa Onagraceae Plantae 1401410

Showing of synonyms

  • Mabou FD, Tamokou JD, et al. (2016). Complex secondary metabolites from Ludwigia leptocarpa with potent antibacterial and antioxidant activities.. Drug discoveries & therapeutics,2016, 10(3), 141-149. [View] [PubMed]

No compound-protein relationship available.

Structure

SMILES: O1CCCCC1OC2CCC(OC2)OC3C(OCCC3)OC(=O)C45C(CCCC5)C=6C(CC4)C7C(CC6)C8C(CC7)CC(CC8)OC9CCCCO9

Level: 4

Mol. Weight: 1247.43 g/mol

Structure

SMILES: O1CCCCC1OC2C(OCCC2)OC(=O)C34C(CCCC4)C=5C(CC3)C6C(CC5)C7C(CC6)CC(CC7)OC8CCCCO8

Level: 3

Mol. Weight: 1247.43 g/mol

Structure

SMILES: C1CCCC(CC2)C1C(CC3)C2C(CC4)C=3C(CCCC5)C45C(=O)OC(OCCC6)C6OC(OC7)CCC7OC8CCCCO8

Level: 3

Mol. Weight: 1247.43 g/mol

Structure

SMILES: O1CCCCC1OC2C(OCCC2)OC(=O)C34C(CCCC4)C=5C(CC3)C6C(CC5)C7C(CC6)CCCC7

Level: 2

Mol. Weight: 1247.43 g/mol

Structure

SMILES: O1CCCCC1OC(=O)C23C(CCCC3)C=4C(CC2)C5C(CC4)C6C(CC5)CC(CC6)OC7CCCCO7

Level: 2

Mol. Weight: 1247.43 g/mol

Structure

SMILES: O1CCCCC1OC2CCC(OC2)OC3CCCOC3

Level: 2

Mol. Weight: 1247.43 g/mol

Structure

SMILES: O1CCCCC1OC(=O)C23C(CCCC3)C=4C(CC2)C5C(CC4)C6C(CC5)CCCC6

Level: 1

Mol. Weight: 1247.43 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CC(CC5)OC6CCCCO6

Level: 1

Mol. Weight: 1247.43 g/mol

Structure

SMILES: C1OCCCC1OC2CCCCO2

Level: 1

Mol. Weight: 1247.43 g/mol

Structure

SMILES: C1CCCC2C1CCC(C2=3)C4C(CC3)C5C(CC4)CCCC5

Level: 0

Mol. Weight: 1247.43 g/mol

Structure

SMILES: C1CCOCC1

Level: 0

Mol. Weight: 1247.43 g/mol

No bioactivities available.

Absorption

Caco-2 (logPapp)
-6.43
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
73549481383.88
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
9612053234456.04

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.59
Plasma Protein Binding
16.94
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Substrate
OATP1B1
Inhibitor
OATP1B3
Inhibitor

Excretion

Clearance
1.65
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Toxic
Bee
Safe
Bioconcentration Factor
-223554610970.4
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Toxic
Liver Injury I (DILI)
Toxic
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
-91280.45
Liver Injury II
Safe
hERG Blockers
Toxic
Daphnia Maga
4.05
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
-17445414429898342
Rat (Acute)
6.37
Rat (Chronic Oral)
37418887.27
Fathead Minnow
22021118581266.766
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Toxic
SR-p53
Safe

General Properties

Boiling Point
1962125552180523.5
Hydration Free Energy
-2.92
Log(D) at pH=7.4
-1090746010.68
Log(P)
-126972.78
Log S
-3.57
Log(Vapor Pressure)
-64611803635250.88
Melting Point
-19629799.95
pKa Acid
-470798910392.35
pKa Basic
-3787562432.16

No predicted protein targets found for this compound.

Download SDF